H. Christensen, M. May, L. Bowen, M. Hickman, and C. L. Trotter, Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, vol.10, issue.10, pp.70251-70257, 2010.

J. A. Bazan, A. N. Turner, R. D. Kirkcaldy, A. C. Retchless, C. B. Kretz et al., Large cluster of neisseria meningitidis urethritis in columbus, Clin Infect Dis, vol.65, pp.92-99, 2015.

R. Acevedo, X. Bai, R. Borrow, D. A. Caugant, J. Carlos et al., The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations, Expert Rev Vaccines, vol.18, pp.15-30, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02013210

J. Rosain, E. Hong, C. Fieschi, P. V. Martins, E. Sissy et al., Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies, J Infect Dis, vol.215, pp.1331-1369, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013257

R. M. Viner, R. Booy, H. Johnson, W. J. Edmunds, L. Hudson et al., Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study, Lancet Neurol, vol.11, pp.774-83, 2012.

I. Parent-du-chatelet, A. E. Deghmane, D. Antona, E. Hong, L. Fonteneau et al., Characteristics and changes in invasive meningococcal disease epidemiology in France, J Infect, vol.74, pp.564-74, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-02013252

F. Caron, I. P. Du-chatelet, J. P. Leroy, C. Ruckly, M. Blanchard et al., From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis, vol.11, pp.455-63, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083160

M. Broker, S. Jacobsson, M. Kuusi, D. Pace, M. J. Simoes et al., Meningococcal serogroup Y emergence in Europe: update, Hum Vaccin Immunother, vol.8, pp.1907-1918, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02085551

E. Hong, A. S. Barret, A. Terrade, M. Denizon, D. Antona et al., Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France, J Infect, vol.76, pp.149-58, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950885

T. Guiddir, M. Gros, E. Hong, A. Terrade, M. Denizon et al., Unusual initial abdominal presentations of invasive meningococcal disease, Clin Infect Dis, vol.67, pp.1220-1247, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950870

M. Krone, S. Gray, R. Abad, A. Skoczynska, P. Stefanelli et al., Increase of invasive meningococcal serogroup W disease in Europe, Euro Surveill, vol.24, 2013.

M. J. Knol, S. Hahne, J. Lucidarme, H. Campbell, H. E. De-melker et al., Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study, Lancet Public Health, vol.2, issue.17, pp.30157-30160, 2017.

A. Khatami, M. D. Snape, E. Davis, H. Layton, T. John et al., Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations, Vaccine, vol.30, pp.2831-2869, 2012.

, Avis relatif à la vaccination par le vaccin méningococcique conjugué de sérogroupe C, HCSP, 2009.

H. J. Larson, A. De-figueiredo, Z. Xiahong, W. S. Schulz, P. Verger et al., The State of Vaccine Confidence 2016: global insights through a 67-country survey, EBioMedicine, vol.12, pp.295-301, 2016.

C. Bassi, M. K. Taha, M. C. Hong, E. Levy-bruhl, D. Barret et al., Mounchetrou Njoya I. A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, Euro Surveill, vol.22, 2017.

A. S. Barret, F. Clinard, M. K. Taha, I. Girard, E. Hong et al., Cluster of serogroup W invasive meningococcal disease in a university campus, Med Mal Infect, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02423494

L. K. Mcneil, R. Donald, A. Gribenko, R. French, N. Lambert et al., Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by bivalent rLP2086, a novel prophylactic vaccine, MBio, vol.9, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950865

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.13, pp.70006-70015, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

R. C. Read, D. Baxter, D. R. Chadwick, S. N. Faust, A. Finn et al., Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial, Lancet, vol.384, pp.2123-2154, 2014.

H. M. Soeters, M. Whaley, A. , N. Kanadanian, K. V. Macneil et al.,

J. Vuong, Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a College-Rhode Island, Clin Infect Dis, vol.64, pp.1115-1137, 2017.

F. Mcquaid, M. D. Snape, T. M. John, S. Kelly, H. Robinson et al., Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months, CMAJ, vol.187, pp.215-238, 2015.

H. S. Marshall, P. C. Richmond, J. Beeslaar, Q. Jiang, K. U. Jansen et al., Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial, Lancet Infect Dis, vol.17, pp.58-67, 2017.

S. R. Parikh, N. J. Andrews, K. Beebeejaun, H. Campbell, S. Ribeiro et al., Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study, Lancet, vol.388, issue.16, pp.31921-31924, 2016.

, Avis du HCSP relatif à l'utilisation du vaccin Bexsero (Novartis Vaccines and Diagnostics), HCSP, 2013.

S. Vygen, W. Hellenbrand, P. Stefanoff, G. Hanquet, S. Heuberger et al., European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007, Euro Surveill, vol.21, pp.23-31, 2016.

K. Sharma, C. Chiu, and N. Wood, Meningococcal vaccines in Australia: a 2019 update, Aust Prescr, vol.42, pp.131-166, 2019.

M. K. Taha, A. E. Deghmane, M. Knol, and A. Van-der-ende, Whole genome sequencing reveals Trans-European spread of an epidemic Neisseria meningitidis serogroup W clone, Clin Microbiol Infect, vol.25, pp.765-67, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02013227

N. J. Oldfield, L. R. Green, J. Parkhill, C. D. Bayliss, and D. Turner, Limited impact of adolescent meningococcal ACWY vaccination on neisseria meningitidis serogroup W carriage in University Students, J Infect Dis, vol.217, pp.608-624, 2018.

O. Sall, B. Stenmark, M. Glimaker, S. Jacobsson, P. Molling et al., Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, Epidemiol Infect, vol.145, pp.2137-2180, 1995.

P. Vienne, M. Ducos-galand, A. Guiyoule, R. Pires, D. Giorgini et al., The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia, Clin Infect Dis, vol.37, pp.1639-1681, 2003.

C. Feldman and R. Anderson, Meningococcal pneumonia: a review, Pneumonia, vol.11, p.3, 2019.

M. Knuf, O. Romain, K. Kindler, U. Walther, P. M. Tran et al., Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study, Eur J Pediatr, vol.172, pp.601-613, 2013.

P. Bryan, S. Seabroke, J. Wong, K. Donegan, E. Webb et al., Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study, Lancet Child Adolesc Health, vol.2, issue.18, pp.30103-30105, 2018.